TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.

By F. Rücker, R. Schlenk, L. Bullinger, S. Kayser, V. Teleanu, Helena Kett, Marianne Habdank, Carla-Maria Kugler, K. Holzmann, V. Gaidzik and 12 more. Blood, 2012

649 citations recorded by the source corpus.

Subfields: Hematology, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/f7af2ec1f1229b2dcc49fe1c8195b3d30a3de812

Citations in the corpus

• Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. (2019, neutral): “9, NR) 46 (35, 56) 51 (36, 64) 45 (30, 59) Not applicable 2-year OS rate, %”